Old Web
English
Sign In
Acemap
>
authorDetail
>
Thuy Anh Sorof
Thuy Anh Sorof
Genentech
Medicine
Ibrutinib
Adverse effect
Internal medicine
Exon
3
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom
2020
J. Xie
Asm Yong
Catherine Waweru
Thuy Anh Sorof
Ravi K. Goyal
Keith L. Davis
Show All
Source
Cite
Save
Citations (1)
Real-World Treatment Patterns and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib in the UK: A Preliminary Analysis
2019
Blood
Jing Xie
Alan Yong
Catherine Waweru
Thuy Anh Sorof
Ravi K Goyal
Keith L. Davis
George A. Follows
Peter Hillmen
Show All
Source
Cite
Save
Citations (1)
Phase II study of vemurafenib in patients with locally advanced, unresectable stage IIIc or metastatic melanoma and activating exon 15 BRAF mutations other than V600E.
2014
Journal of Clinical Oncology
Sigrun Hallmeyer
Omid Hamid
Thuy Anh Sorof
Yong Mun
Shiyao Liu
Sarang Abhyankar
Geoffrey T. Gibney
Igor Puzanov
Show All
Source
Cite
Save
Citations (4)
1